Press releases

Filter
All
Health
Inkef
Tech

iOnctura

iOnctura announces first subject dosed in healthy volunteer study of next generation autotaxin inhibitor IOA-289.
July 20 / 2021

Castor

Castor raises USD 45m Series B to modernize the clinical trial process and maximize impact of research data on patient lives.
July 14 / 2021

Remote

Remote has raised a USD 150m Series B round at a valuation of more than USD 1 billion.
July 13 / 2021

Salvia BioElectronics

Salvia BioElectronics appoints Dr Alan Levy as Chairman
July 2 / 2021

Draupnir Bio

Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
June 23 / 2021

Sentinels

INKEF leads the Seed Financing of Sentinels, alongside strategic angel investors and industry leaders.
June 2 / 2021

QurAlis

QurAlis Boosts World-Class Leadership Team With Addition of Three New Members
May 26 / 2021

bloomon

British online florist Bloom & Wild acquires Dutch bloomon to become Europe's number 1
April 22 / 2021

Anavo Therapeutics

Anavo Therapeutics Launches with EUR 20 Million Seed Financing and investors INKEF Capital, M Ventures, Taiho Ventures and Bioqube Ventures. Anavo aims to Create a Industry-Leading Pipeline of Allosteric Phosphatase Modulators.
April 22 / 2021

Lengoo

Berlin-based language tech company Lengoo announces a USD 20M Series B funding round
February 10 / 2021

Scenic Biotech

Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman
February 3 / 2021

VarmX

VarmX appoints Dr. Gerard Short as Chief Medical Officer
January 27 / 2021

ChannelEngine

INKEF leads Series A Financing of ChannelEngine.
January 19 / 2021

Onward

ONWARD Announces First Patient Enrolled in the Up-LIFT Pivotal Trial Assessing Safety and Effectiveness of ARC Therapy for Spinal Cord Injury
January 13 / 2021

Calypso Biotech

Calypso Biotech announces successful dosing of first Phase 1 cohort with anti-Interleukin-15 (IL-15) monoclonal antibody CALY-002 for the treatment of Autoimmune Diseases
December 9 / 2020

QurAlis

This Wednesday, the New England Venture Capital Association (NEVCA) honored the winners of its eighth annual NEVY Awards, recognizing and celebrating the top innovators, investors and companies in the region. In the Life Sciences category, Quralis has been named as the winner of the "Emerging Life Sciences Company of the Year” award. Full story can be found below.
December 3 / 2020

EclecticIQ

EclecticIQ, a global threat intelligence, hunting and response technology provider, has raised €20 million ($24 million) in Series C financing, led by Ace Management, Europe’s leading cyber growth investor.
December 1 / 2020

Quantum Motion

Quantum Motion appoints Cadence founder and industry expert Prof. Alberto Sangiovanni-Vincentelli as Chair
November 12 / 2020

Remote

Remote raises $35M to help orgs with global workforce payroll, benefits and more
November 11 / 2020

Salvia BioElectronics

Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution
November 3 / 2020

QurAlis

QurAlis Announces Appointment of New Chief Medical Officer and Formation of Clinical Advisory Board
October 29 / 2020

Silverflow

Adyen alums get €3m to launch Silverflow, the first cloud-native card payments platform that connects directly to card networks Crane Venture Partners and Inkef Capital back Adyen alum startup Silverflow to transform online card payments processing providing an instant upgrade to thousands of ...
October 22 / 2020

INKEF

Our healthcare managing partner Roel Bulthuis has joined the Social Pact signed by biotech leaders worldwide, pledging to hold up, together with the rest of the Inkef team, the moral obligation to develop the best medicines and ensure access to all who are in need.
October 14 / 2020

QurAlis

FierceBiotech Names QurAlis as One of the "Fierce 15" Biotech Companies of 2020   This Monday, FierceBiotech has announced the winners of its annual “Fierce 15” nomination, which highlights the most promising private biotechnology companies in the industry. Inkef’s portfolio company ...
September 29 / 2020

Salvia BioElectronics

Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Series A led by new investors Panakès Partners, INKEF Capital and SHS Gesellschaft für Beteiligungsmanagement
September 22 / 2020

Scenic Biotech

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech   Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease modifying approach Utilises Scenic’s unique Cell-Seq platform and its proprietary data ...
September 21 / 2020

AITO

Aito Raises €3 Million Investment Led by KBC Focus Fund Amsterdam, August 31, 2020 – Aito is excited to announce that we have successfully raised a €3 million investment led by KBC Focus Fund, with participation from FORWARD.one and existing investor, Innovation Industries.  The new ...
September 1 / 2020

Castor

Castor Raises a $12M Series A to Further Their Support for COVID-19 Research Through Clinical Trial and Data Automation  With 4,000 live studies and 2,000,000 enrolled patients across 90 countries, Castor will use the funding to further invest in enabling patient-centric, data-powered clinical ...
August 19 / 2020

Blendle

Cafeyn Group has acquired Blendle to become the leading European newspaper and magazine information streaming platform Offering more than 2500 newspapers and magazines and serving 1.5 million active users inFrance, Germany, the Netherlands, Belgium, Italy, the United Kingdom, Ireland, Austria, ...
July 30 / 2020

NMD Pharma

NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis Aarhus, Denmark, 14 July 2020 – NMD Pharma A/S, a biotech company leading in the development of novel therapeutics for neuromuscular disorders, today ...
July 14 / 2020

iOnctura

iOnctura Extends Series A to EUR 20.1M 3B Future Health Fund Joins Blue Chip Investor Syndicate Accelerate Development of Next Generation Molecules Targeting Cancer and Fibrosis   Geneva, Switzerland, [14] July 2020: iOnctura SA, a clinical stage biopharmaceutical company, developing ...
July 14 / 2020

ViCentra

ViCentra announces closing of a €10 million investment round to fund its international growth July 7th, 2020 – ViCentra, the company behind Kaleido, the world’s smallest and lightest insulin pump, announced the closing of a €10 million investment round. On June 30, 2020, ViCentra and ...
July 8 / 2020

VarmX

VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants
July 8 / 2020

Gtx Medical

GTX Medical Appoints Dave Marver as Chief Executive Officer Eindhoven, NL; July 2, 2020 – GTX Medical (‘GTX’) announced today the appointment of Dave Marver as Chief Executive Officer. Mr. Marver is a highly experienced medtech leader. He will guide GTX through the development and ...
July 6 / 2020

QurAlis

QurAlis Announces Agreement to Strengthen ALS Pipeline CAMBRIDGE, Mass.-- QurAlis Corporation, a biotech company focused on developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, today announced an agreement to in-license pre-clinical compounds with ...
July 2 / 2020

Gtx Medical

GTX medical Granted FDA Breakthrough Device Designation for Go-2 Targeted Epidural Spinal Stimulation (TESS) System    Eindhoven, NL and Lausanne, CH: June 9, 2020 - GTX medical (GTX), today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...
June 9 / 2020

Happeo

Happeo raises $12M in Series A funding to further disrupt the intranet industry Amsterdam, 20th May 2020 - Social intranet platform Happeo announces to have raised $12M in a Series A funding round led by INKEF Capital. Happeo’s previous investors DN Capital, Maki.vc and Vendep Capital also ...
May 20 / 2020

Quantum Motion

Quantum Motion raises £8m in oversubscribed series A fundraising Quantum Motion Technologies Ltd (QMT), a UK based quantum computing company founded on world leading silicon spin technology and architectures developed at UCL and Oxford University, today announced it has completed an £8.0m ...
May 14 / 2020

QurAlis

QurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS) Funding led by Polaris Partners, Mission BioCapital, INKEF Capital and the Dementia Discovery Fund CAMBRIDGE, Mass., May 13, 2020-- QurAlis Corporation, a biotech company focused on ...
May 13 / 2020

Remote

Remote Raises an $11M Seed Round to Empower Companies to Hire and Onboard Talent Anywhere in The World Within Minutes Funding will enhance the infrastructure for global remote work and extend the platform’s coverage across 40 new international markets SAN FRANCISCO, April 22nd, 2020 - ...
April 22 / 2020

iOnctura

iOnctura announces first patient dosed in a phase I clinical study of its novel highly selective PI3Kδ inhibitor, IOA-244 for solid tumours
February 26 / 2020

iOnctura

iOnctura raises EUR 15 million in Series A financing to progress its pipeline into clinical development Amsterdam, The Netherlands, January 23, 2020: iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, ...
January 23 / 2020

GTX medical BV

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury   Eindhoven, NL and Lausanne, CH; Los Angeles, USA; October 22, 2019 - GTX medical BV (‘GTX’, formerly known as G-Therapeutics) and NeuroRecovery Technologies Inc. ...
October 24 / 2019

Cashforce

Founded in 2012, Cashforce products help large enterprises with getting more accurate cash flow forecasts and with managing working capital at a company-wide level while also providing granular insights down to the transaction level by integrating with existing ERP and TMS implementations.
October 24 / 2019

Urban Sports Club

Urban Sports Club, the German sports and fitness platform, and its Dutch peer OneFit have signed agreements to join forces. The transaction, which is expected to become effective later this month, will enable both companies to expand their offer for both private and corporate customers.
August 8 / 2019

Calypso Biotech

Calypso Biotech BV secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases. Amsterdam, 20 February 2019 Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune diseases, ...
February 22 / 2019

Aidence

AI-company Aidence raises €10 million Series A to revolutionise the medical imaging industry     Amsterdam 20/02/2019- Aidence, a company that is bringing the full potential of Artificial Intelligence into the hands of medical professionals in medical imaging and disease ...
February 20 / 2019

Geophy

AI-powered property valuation platform GeoPhy secures $33M to bring transparency to the real estate market
January 24 / 2019

Polarsteps

Founded in 2015, Polarsteps is used by over 1 million travelers in 180+ countries to track their trips and share them in real time with their closest friends and family. Polarsteps wants to inspire and connect people through travel. It believes that the best way to do that is by creating a place where the entire travel experience is combined within one platform. From the very first inspiration on where to go, to remembering your trip years after it has ended. The Amsterdam-based startup is therefore building the place to go to for travelers that want to plan, track and remember their adventures around the globe.
January 17 / 2019

INKEF

INKEF Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund Venture fund focuses on supporting early stage healthcare and tech companies 27 November 2018, Amsterdam: INKEF Capital (INKEF), the Dutch venture capital fund focused on technology and healthcare, ...
November 27 / 2018

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors   (San Leandro, California, May 9, 2018) BioClin Therapeutics, Inc., a clinical stage drug development company developing a first-in-class anti-FGFR3 (fibroblast growth factor receptor ...
May 15 / 2018

Nightbalance

Royal Philips today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands.
May 8 / 2018

Onefit

OneFit Secures € 4.25 Million Series A financing led by INKEF Capital.
May 1 / 2018

Shapeways

Shapeways Announces $30M in New Funding Led by Lux Capital: Series E Funding Will Accelerate Shapeways’ Expansion.
April 19 / 2018

NMD Pharma

NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders.
March 23 / 2018

Blendle Audio

Vandaag introduceren we Blendle Audio. Het is de grootste stap sinds onze oprichting, en de meest gevraagde functie van onze gebruikers.
January 11 / 2018

EclecticIQ

EclecticIQ lands Series-B investment of €14 million to make Cyber Threat Intelligence accessible to organizations at any level of cyber readiness.
November 14 / 2017

Withlocals

Withlocals Raises $4.1M in Series A Funding. Leading global marketplace for personalized tours and activities to expand into 40 more cities.
October 11 / 2017

Scenic Biotech

Scenic Biotech’s ‘genetic off-switch’ for disease secures major investment to accelerate development.
June 13 / 2017

Blendle

Amsterdam-based investment fund INKEF Capital, and Japanese media group Nikkei, owner of global business news publisher Financial Times, are investing in the Netherlands-based startup Blendle.
April 19 / 2017

Inkef

INKEF Capital increases fund to € 500 Million.
September 8 / 2016

NightBalance

NightBalance closes EUR 12.5 million Series B financing led by INKEF Capital.
July 5 / 2016

EclecticIQ

EclecticIQ raises 5.5 million Euro for enterprise-ready cyber threat intelligence (CTI) platform.
May 20 / 2016

GeoPhy

Press release: GeoPhy announces strategic partnership with ABP and its asset manager APG.
May 21 / 2016

G-Therapeutics

Implantaat biedt hoop voor patiënten met dwarslaesie.
April 19 / 2016

Inkef

ABP investeert nog eens € 100 miljoen in Nederlands MKB.
April 17 / 2015

Crowdynews

Crowdynews completes Series A extension funding, led by INKEF Capital.
February 9 / 2016

Wercker

Wercker Announces $4.5 Million in Series A Funding led by Inkef Capital.
January 29 / 2016

Inkef

INKEF team members Lucas and Mirella finished the NYC marathon 2015.
November 12 / 2015

Audion

Audion Therapeutics raises funds from INKEF Capital to advance the development of hearing loss treatment.
September 8 / 2015

Bloomon

Bloomon raises 3.5 million Euros from international investors.
September 4 / 2015

Shapeways

Shapeways Raises $30 Million in Funding led By INKEF Capital.
June 30 / 2015

Lanthio

INKEF Capital Portfolio Company Lanthio Pharma Acquired by MorphoSys.
May 11 / 2015

Inkef

Team INKEF successfully completed Man of Steel Run April 2015.
April 28 / 2015

NPEX

Eigen kapitaalmarkt voor het MKB krijgt boost door NPEX Ondernemersfonds.
April 17 / 2015
Privacy Policy Copyright 2021 © Inkef Capital